Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative-Reference-Cited by-同舟云学术

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative

Published:2018-09-18 Issue:1 Volume:111 Page:95-98
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Caswell-Jin Jennifer L¹,Zimmer Anjali D¹²,Stedden Will³,Kingham Kerry E¹,Zhou Alicia Y²,Kurian Allison W¹⁴

Affiliation:

1. Department of Medicine, Stanford University School of Medicine, Stanford, CA

2. Department of Scientific Affairs, Color Genomics, Burlingame, CA

3. Department of Data Science, Color Genomics, Burlingame, CA

4. Department of Health Research & Policy, Stanford University School of Medicine, Stanford, CA

Funder

Color Genomics

BRCA Foundation

Damon Runyon Cancer Research Foundation

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/111/1/95/27441603/djy147.pdf

Reference19 articles.

1. NCCN guidelines insights: Genetic/familial high-risk assessment: breast and ovarian, Version 2.2017;Daly;J Natl Compr Canc Netw,2017

2. Traceback: A proposed framework to increase identification and genetic counseling of BRCA1 and BRCA2 mutation carriers through family-based outreach;Samimi;J Clin Oncol,2017

3. Cascade screening for familial hypercholesterolemia: Practical consequences;Louter;Atheroscler Suppl,2017

4. Cascade screening for familial hypercholesterolemia and the use of genetic testing;Knowles;JAMA,2017

5. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases;George;J Genet Counsel,2015

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline;Journal of Clinical Oncology;2024-01-04

2. Direct letters to relatives at risk of hereditary cancer—study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study);Trials;2023-12-17

3. Applying the framework for developing and evaluating complex interventions to increase family communication about hereditary cancer;PEC Innovation;2023-12

4. Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing;Cancers;2023-10-30

5. Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes;Journal of Genetic Counseling;2023-10-25